Literature DB >> 28195678

Biochemical evaluation of interactions between synergistic molecules and phase I enzymes involved in insecticide resistance in B- and Q-type Bemisia tabaci (Hemiptera: Aleyrodidae).

Michela Panini1,2, Francesco Tozzi3, Christoph T Zimmer4,5, Chris Bass4,5, Linda Field5, Valerio Borzatta3, Emanuele Mazzoni2, Graham Moores1.   

Abstract

BACKGROUND: Metabolic resistance is an important consideration in the whitefly Bemisia tabaci, where an esterase-based mechanism has been attributed to pyrethroid resistance and over-expression of the cytochrome P450, CYP6CM1, has been correlated to resistance to imidacloprid and other neonicotinoids.
RESULTS: In vitro interactions between putative synergists and CYP6CM1, B and Q-type esterases were investigated, and structure-activity relationship analyses allowed the identification of chemical structures capable of acting as inhibitors of esterase and oxidase activities. Specifically, methylenedioxyphenyl (MDP) moieties with a polyether chain were preferable for optimum inhibition of B-type esterase, whilst corresponding dihydrobenzofuran structures were potent for the Q-esterase variation. Potent inhibition of CYP6CM1 resulted from structures which contained an alkynyl chain with a terminal methyl group.
CONCLUSIONS: Synergist candidates could be considered for field control of B. tabaci, especially to abrogate neonicotinoid resistance.
© 2017 Society of Chemical Industry. © 2017 Society of Chemical Industry.

Entities:  

Keywords:  Bemisia tabaci; P450s; SAR; esterase; piperonyl butoxide; synergist

Mesh:

Substances:

Year:  2017        PMID: 28195678     DOI: 10.1002/ps.4553

Source DB:  PubMed          Journal:  Pest Manag Sci        ISSN: 1526-498X            Impact factor:   4.845


  1 in total

1.  Cytochrome P450 and Glutathione S-Transferase Confer Metabolic Resistance to SYP-14288 and Multi-Drug Resistance in Rhizoctonia solani.

Authors:  Xingkai Cheng; Tan Dai; Zhihong Hu; Tongshan Cui; Weizhen Wang; Ping Han; Maolin Hu; Jianjun Hao; Pengfei Liu; Xili Liu
Journal:  Front Microbiol       Date:  2022-03-21       Impact factor: 5.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.